Mindfulness meditation training may improves depression symptoms and reduce the incidence of major depression, a new study suggests.
Patients with clinically significant symptoms of depression who do not meet the criteria for major depressive disorder or dysthymic disorder are considered to have sub-threshold depression.
According to the researchers from The Jockey Club School of Public Health and Primary Care in Hong Kong, sub-threshold depression can cause functional impairment and considerable economic costs, and it is a strong risk factor for developing major depressive disorder.
The study, published in the journal Annals of Family Medicine, undertook a randomised controlled trial to assess the efficacy of group-based behavioural activation with mindfulness (BAM) for treating sub-threshold depression.
The researchers recruited adult patients aged 18 and above with sub-threshold depression from public primary care clinics and randomly assigned them to a BAM intervention group or a usual care group.
They randomly allocated 115 patients to the BAM intervention and 116 patients to usual care.
The BAM group was provided with eight two-hour weekly BAM sessions by trained allied health care workers. Patients in the usual care group received usual medical care with no additional psychological interventions.
The primary outcome was depressive symptoms measured by the Beck Depression Inventory-II at 12 months. Secondary outcomes included incidence of major depressive disorder at 12 months.
We assessed quality of life, activity and circumstances change, functional impairment, and anxiety at baseline, end of intervention, 5 months, and 12 months, the researchers said.
At 12 months, compared with usual care peers, BAM patients had a slightly more favourable change in levels of depressive symptoms on the Beck Depression Inventory-II.
Incidence of major depressive disorder was lower with BAM, whereas groups did not differ significantly on other secondary outcomes at 12 months.
The researchers, including Samuel Y. S. Wong, suggested that BAM group appears to be efficacious for decreasing depressive symptoms and reducing the incidence of major depression among patients with sub-threshold depression in primary care.
--IANS
vc/nks/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
